Perspective Therapeutics (CATX) Change in Cash (2016 - 2026)

Perspective Therapeutics' Change in Cash history spans 17 years, with the latest figure at $23.3 million for Q1 2026.

  • On a quarterly basis, Change in Cash rose 235.92% to $23.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $9.6 million, a 109.77% increase, with the full-year FY2025 number at -$31.0 million, down 159.34% from a year prior.
  • Change in Cash hit $23.3 million in Q1 2026 for Perspective Therapeutics, up from $3.9 million in the prior quarter.
  • Over the last five years, Change in Cash for CATX hit a ceiling of $132.9 million in Q1 2024 and a floor of -$164.9 million in Q4 2024.
  • Historically, Change in Cash has averaged -$2.6 million across 5 years, with a median of -$8.1 million in 2023.
  • The widest YoY moves for Change in Cash: up 1451.13% in 2024, down 1785.23% in 2024.
  • Tracing CATX's Change in Cash over 5 years: stood at -$34.9 million in 2022, then skyrocketed by 74.94% to -$8.7 million in 2023, then crashed by 1785.23% to -$164.9 million in 2024, then skyrocketed by 102.35% to $3.9 million in 2025, then surged by 503.65% to $23.3 million in 2026.
  • Business Quant data shows Change in Cash for CATX at $23.3 million in Q1 2026, $3.9 million in Q4 2025, and -$2.1 million in Q3 2025.